ID

34996

Description

Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET; ODM derived from: https://clinicaltrials.gov/show/NCT02261389

Lien

https://clinicaltrials.gov/show/NCT02261389

Mots-clés

Versions (1)
  1. 07/02/2019 07/02/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

7 février 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT02261389

Anglais

Eligibility Breast Cancer NCT02261389

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female ≥18 years.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
histologically confirmed stage i-iii epithelial breast cancer.
Description

Breast Carcinoma epithelial TNM Breast tumor staging

Type de données

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0221908
UMLS CUI [1,3]
C0474926
adequate surgery of breast and axilla:
Description

Operation on breast | Axilla Operative Surgical Procedures

Type de données

boolean

Alias
UMLS CUI [1]
C3714726
UMLS CUI [2,1]
C0004454
UMLS CUI [2,2]
C0543467
1. patients must have undergone either a total mastectomy or breast conserving surgery
Description

Total mastectomy | Breast-Conserving Surgery

Type de données

boolean

Alias
UMLS CUI [1]
C0024886
UMLS CUI [2]
C0917927
2. surgical margins of the resected specimen must be histologically free of invasive tumor.
Description

Specimen Resected | Surgical margins Free of Invasive cancer

Type de données

boolean

Alias
UMLS CUI [1,1]
C0370003
UMLS CUI [1,2]
C1521996
UMLS CUI [2,1]
C0229985
UMLS CUI [2,2]
C0332296
UMLS CUI [2,3]
C0677898
signed informed consent obtained prior to any study-specific procedures.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
histologically confirmed stage 0 epithelial breast cancer (carcinoma in situ).
Description

Breast Carcinoma epithelial TNM Breast tumor staging

Type de données

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0221908
UMLS CUI [1,3]
C0474926
special histologies with a high or low risk of relapse (i.e. sarcoma and tubular carcinoma)
Description

Histology High risk of Relapse | Histology Low Risk Relapse | Sarcoma | Carcinoma, Tubular

Type de données

boolean

Alias
UMLS CUI [1,1]
C4048239
UMLS CUI [1,2]
C0332167
UMLS CUI [1,3]
C0035020
UMLS CUI [2,1]
C4048239
UMLS CUI [2,2]
C3538919
UMLS CUI [2,3]
C0035020
UMLS CUI [3]
C1261473
UMLS CUI [4]
C0205645
t1a and t1b tumors with all the following characteristics: g1-2 and n0 and re > 10%, rpg > 10% and her2 negative and ki67≤14%
Description

Malignant Neoplasms TNM Breast tumor staging | Estrogen Receptor Measurement | Progesterone Receptor Measurement | HER2 Negative | Ki67 Measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0474926
UMLS CUI [2]
C3811131
UMLS CUI [3]
C3889640
UMLS CUI [4]
C2348908
UMLS CUI [5]
C4049944
evidence of distant metastases
Description

Distant metastasis

Type de données

boolean

Alias
UMLS CUI [1]
C1269798
patients participating to other clinical trials requiring follow-up not equal to standard
Description

Study Subject Participation Status | Requirement Follow-up Special

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C3274571
UMLS CUI [2,3]
C0205555
previous history of cancer within 5 years from randomization (except for appropriately treated carcinoma in situ of the cervix, non-melanoma skin carcinoma, stage i uterine cancer, or other non-breast malignancies with an outcome similar to those mentioned above)
Description

Malignant Neoplasms | Exception Carcinoma in situ of uterine cervix Treated | Exception Skin carcinoma Treated | Exception Uterine Cancer TNM clinical staging Treated

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0851140
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0699893
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0153567
UMLS CUI [4,3]
C3258246
UMLS CUI [4,4]
C1522326
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT02261389

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male or female ≥18 years.
boolean
C0001779 (UMLS CUI [1])
Breast Carcinoma epithelial TNM Breast tumor staging
Item
histologically confirmed stage i-iii epithelial breast cancer.
boolean
C0678222 (UMLS CUI [1,1])
C0221908 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,3])
Operation on breast | Axilla Operative Surgical Procedures
Item
adequate surgery of breast and axilla:
boolean
C3714726 (UMLS CUI [1])
C0004454 (UMLS CUI [2,1])
C0543467 (UMLS CUI [2,2])
Total mastectomy | Breast-Conserving Surgery
Item
1. patients must have undergone either a total mastectomy or breast conserving surgery
boolean
C0024886 (UMLS CUI [1])
C0917927 (UMLS CUI [2])
Specimen Resected | Surgical margins Free of Invasive cancer
Item
2. surgical margins of the resected specimen must be histologically free of invasive tumor.
boolean
C0370003 (UMLS CUI [1,1])
C1521996 (UMLS CUI [1,2])
C0229985 (UMLS CUI [2,1])
C0332296 (UMLS CUI [2,2])
C0677898 (UMLS CUI [2,3])
Informed Consent
Item
signed informed consent obtained prior to any study-specific procedures.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Breast Carcinoma epithelial TNM Breast tumor staging
Item
histologically confirmed stage 0 epithelial breast cancer (carcinoma in situ).
boolean
C0678222 (UMLS CUI [1,1])
C0221908 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,3])
Histology High risk of Relapse | Histology Low Risk Relapse | Sarcoma | Carcinoma, Tubular
Item
special histologies with a high or low risk of relapse (i.e. sarcoma and tubular carcinoma)
boolean
C4048239 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C0035020 (UMLS CUI [1,3])
C4048239 (UMLS CUI [2,1])
C3538919 (UMLS CUI [2,2])
C0035020 (UMLS CUI [2,3])
C1261473 (UMLS CUI [3])
C0205645 (UMLS CUI [4])
Malignant Neoplasms TNM Breast tumor staging | Estrogen Receptor Measurement | Progesterone Receptor Measurement | HER2 Negative | Ki67 Measurement
Item
t1a and t1b tumors with all the following characteristics: g1-2 and n0 and re > 10%, rpg > 10% and her2 negative and ki67≤14%
boolean
C0006826 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C3811131 (UMLS CUI [2])
C3889640 (UMLS CUI [3])
C2348908 (UMLS CUI [4])
C4049944 (UMLS CUI [5])
Distant metastasis
Item
evidence of distant metastases
boolean
C1269798 (UMLS CUI [1])
Study Subject Participation Status | Requirement Follow-up Special
Item
patients participating to other clinical trials requiring follow-up not equal to standard
boolean
C2348568 (UMLS CUI [1])
C1514873 (UMLS CUI [2,1])
C3274571 (UMLS CUI [2,2])
C0205555 (UMLS CUI [2,3])
Malignant Neoplasms | Exception Carcinoma in situ of uterine cervix Treated | Exception Skin carcinoma Treated | Exception Uterine Cancer TNM clinical staging Treated
Item
previous history of cancer within 5 years from randomization (except for appropriately treated carcinoma in situ of the cervix, non-melanoma skin carcinoma, stage i uterine cancer, or other non-breast malignancies with an outcome similar to those mentioned above)
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0851140 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0153567 (UMLS CUI [4,2])
C3258246 (UMLS CUI [4,3])
C1522326 (UMLS CUI [4,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial